Search - tctmd.com

Displaying 61 - 80 of 146

Sort: Relevancy | Date

News Daily News ACC 2020

Mental Stress-Induced Ischemia Increases Risk of Poor Outcomes Post-MI

Michael O'Riordan

March 23, 2020

News Conference News ACC 2019

Myocardial Injury Often Miscoded as Type 2 MI

L.A. McKeown

April 02, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Conference News ACC 2019

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

L.A. McKeown

March 27, 2019

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

News Conference News ACC 2019

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

Shelley Wood

March 19, 2019

Presentation ACC 2019

The SAfety and Efficacy of Femoral Access vs RadIal Access in STEMI: The SAFARI-STEMI Trial

Presenter: Michel R Le May

March 19, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

Presentation ACC 2019

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Presenter: Renato Lopes

March 18, 2019

News Conference News ACC 2019

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

L.A. McKeown

March 18, 2019

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Caitlin E. Cox

March 17, 2019

Presentation ACC 2019

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

Presenter: Adam D. DeVore

March 17, 2019

News Conference News ACC 2019

CODIACS-QoL: Depression Screening in ACS Patients Fails to Boost Quality of Life

L.A. McKeown

March 16, 2019

News Conference News ACC 2019

Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks

Todd Neale

March 07, 2019

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Yael L. Maxwell

March 19, 2018

News Conference News ACC 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Yael L. Maxwell

March 14, 2018

News Conference News ACC 2018

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

Yael L. Maxwell

March 12, 2018

Advertisement

Mental Stress-Induced Ischemia Increases Risk of Poor Outcomes Post-MI

Myocardial Injury Often Miscoded as Type 2 MI

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

Time and Money: PCI Public Reporting Requirements Take Their Toll

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

The SAfety and Efficacy of Femoral Access vs RadIal Access in STEMI: The SAFARI-STEMI Trial

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

CODIACS-QoL: Depression Screening in ACS Patients Fails to Boost Quality of Life

Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content